Renaissance BioScience Corp. to receive R&D funding to advance its yeast-based RNAi biopesticide and biotherapeutics technology
Enzymicals and Syngulon sign a non-exclusive license agreement on the use of Syngulon’s antibiotic free technology to produce enzymes
As Zymergen Buys EnEvolv, Biological Manufacturing Is Ready To Transform How Industry Makes Everything From Airplanes To Air Jordans
SGI-DNA Launches Vmax™ X2, the Most Innovative Product in the Competent Cells Market Since the Discovery of E. coli
